SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-006817
Filing Date
2024-03-06
Accepted
2024-03-06 16:11:29
Documents
17
Period of Report
2024-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20240305_8k.htm   iXBRL 8-K 24401
2 EXHIBIT 99.1 ex_635366.htm EX-99.1 222020
7 logo.jpg GRAPHIC 2995
  Complete submission text file 0001437749-24-006817.txt   399431

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240306.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240306_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240306_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240306_pre.xml EX-101.PRE 11583
18 EXTRACTED XBRL INSTANCE DOCUMENT acrx20240305_8k_htm.xml XML 2826
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 24725974
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)